David Conway oversees clinical trials at MetVital. Mr Conway has over 25 years of professional experience in the Pharmaceutical, Biopharmaceutical, and Medical Diagnostic industry. This includes experience in clinical research, development, and clinical operations. Mr Conway’s experience includes direct managerial responsibility for Clinical and Medical Operations Departments in US and Europe with direct responsibility for clinical studies, project management of US and European clinical studies, management of clinical research personnel, and direct hands-on experience in the writing of IBs, protocols, CRF’s, statistical analysis plans, Clinical Study Reports, IND’s, BLA’s/NDA’s, Type B and C Meeting Briefing Books, pre IDEs, and CE Mark applications. Mr Conway has directed coordination of large multi-national pivotal clinical studies that have led to the approval of several novel drugs, drug applications and diagnostic devices. This includes HYQVIA, MabThera SC, Herceptin SC, Anzemet®, Infergen®, NGAL CE Mark, and Nutre-Store L-Glutamine® Mr Conway has a BS in Microbiology from Colorado State University, MS Pharm. from University of Missouri-Kansas City and MT(ASCP) from The Trinity Lutheran Hospital in Kansas City, MO.